LEO 158968

DRUG2 trials

Sponsors

LEO Pharma

Conditions

Gout FlaresHealthyJoint InflammationJoint Pain

Phase 1

Investigating the Safety of LEO 158968 in Healthy Volunteers

CompletedNCT05682352

LEO PharmaHealthy

Start: 2023-02-07End: 2024-08-01Updated: 2026-04-28

A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

CompletedNCT06444867

LEO PharmaGout Flares, Joint Inflammation, Joint Pain

Start: 2025-01-07End: 2025-09-18Updated: 2026-05-12